GI
AMED

GAMCO Investors’s Amedisys AMED Stock Holding History

GAMCO Investors’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-15,000
Closed -$1.48M – 1018
2025
Q2 		$1.48M Sell
15,000
-5,500
-27% -$520K 0.01% 596
2025
Q1 		$1.9M Sell
20,500
-9,834
-32% -$907K 0.02% 494
2024
Q4 		$2.75M Buy
30,334
+159
+0.5% +$14.6K 0.03% 455
2024
Q3 		$2.91M Sell
30,175
-2,000
-6% -$195K 0.03% 441
2024
Q2 		$2.95M Buy
32,175
+597
+2% +$55.4K 0.03% 425
2024
Q1 		$2.91M Sell
31,578
-1,400
-4% -$131K 0.03% 429
2023
Q4 		$3.13M Buy
32,978
+2,625
+9% +$245K 0.03% 409
2023
Q3 		$2.83M Buy
30,353
+20,878
+220% +$1.93M 0.03% 413
2023
Q2 		$866K Buy
+9,475
New +$777K 0.01% 600

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

GAMCO Investors's AMED Position: Q3 2025 in Review

GAMCO Investors sold out of Amedisys (AMED) in Q3 2025, closing a stake of 15,000 shares — an estimated $1.48M sold.

GAMCO Investors first reported a position in AMED in Q2 2023 and held it in 9 quarters. The position peaked at $3.13M in Q4 2023. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • GAMCO Investors reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • GAMCO Investors sold 15,000 Amedisys shares in Q3 2025, an estimated $1.48M.
  • GAMCO Investors first reported a position in Amedisys in Q2 2023 and held it in 9 quarters.
  • GAMCO Investors's Amedisys position peaked at $3.13M in Q4 2023.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on GAMCO Investors's 13F filing for Q3 2025, filed 12 Nov 2025.